Recent studies demonstrated that chitosan oligosaccharides promoted weight loss, reduced plasma glucose levels, normalized insulin contents, and decreased the levels of triglycerides (TG), total cholesterol (TC), and low-density lipoprotein cholesterol (LDL-C) in hyperglycemic mice (type 2 diabetes mellitus model). The gene discussed is INS; the disease is type 2 diabetes mellitus.